R E Carr, P Henkind, N Rothfield, I M Siegel. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdolescentAdultAntimalarials/administration & dosageAntimalarials/adverse effectsChildChild, PreschoolChloroquine/administration & dosageChloroquine/adverse effectsElectrooculographyElectroretinographyEye Diseases/chemically inducedFollow-Up StudiesFundus OculiHumansHydroxychloroquine/administration & dosageHydroxychloroquine/adverse effectsLightLupus Erythematosus, Systemic/drug therapyMacula Lutea/drug effectsMiddle AgedOphthalmoscopyQuinacrine/administration & dosageQuinacrine/adverse effectsRetinitis/chemically inducedVision TestsVisual Fields
Substances: See more » AntimalarialsHydroxychloroquineChloroquineQuinacrine
Year: 1968 PMID: 5729592 DOI: 10.1016/0002-9394(68)91300-7
Source DB: PubMed Journal: Am J Ophthalmol ISSN: 0002-9394 Impact factor: 5.258